The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here are three value stocks with strong fundamentals.
Brady (BRC)
Forward P/E Ratio: 13x
Founded in 1914 and evolving through more than a century of industrial innovation, Brady (NYSE:BRC) manufactures and supplies identification solutions and workplace safety products that help companies identify and protect their premises, products, and people.
Why Are We Bullish on BRC?
- Annual revenue growth of 11.3% over the past two years was outstanding, reflecting market share gains this cycle
- Market share is on track to rise over the next 12 months as its 74% projected revenue growth implies demand will accelerate from its two-year trend
- Free cash flow margin expanded by 5.8 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
Brady’s stock price of $83.97 implies a valuation ratio of 13x forward P/E. Is now the time to initiate a position? See for yourself in our comprehensive research report, it’s free.
Tenet Healthcare (THC)
Forward P/E Ratio: 12.6x
With a network spanning nine states and serving primarily urban and suburban communities, Tenet Healthcare (NYSE:THC) operates a nationwide network of hospitals, ambulatory surgery centers, and outpatient facilities providing acute care and specialty healthcare services.
Why Could THC Be a Winner?
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 18.6% exceeded its revenue gains over the last five years
- Free cash flow margin grew by 11.7 percentage points over the last five years, giving the company more chips to play with
- Rising returns on capital show management is finding more attractive investment opportunities
At $261.78 per share, Tenet Healthcare trades at 12.6x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Nubank (NU)
Forward P/E Ratio: 14x
With well over one hundred million customers across Brazil, Mexico, and Colombia through its viral member-get-member referral program, Nubank (NYSE:NU) is a digital banking platform that offers financial services including spending, saving, investing, borrowing, and protection products to millions of customers across Latin America.
Why Will NU Beat the Market?
- Annual revenue growth of 41.1% over the past two years was outstanding, reflecting market share gains this cycle
- Incremental sales significantly boosted profitability as its annual earnings per share growth of 48.7% over the last two years outstripped its revenue performance
- ROE punches in at 15.9%, illustrating management’s expertise in identifying profitable investments
Nubank is trading at $13.68 per share, or 14x forward P/E. Is now the time to initiate a position? See for yourself in our in-depth research report, it’s free.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.